中文
Product Pipeline
Nucleic acid drug pipeline
Project code
Target
Indications
Preclinical study
IND application
Clinical Phase I
Clinical Phase II
Clinical Phase III
HC0201
AKT-1
Primary renal
HC0201

Targets :AKT-1

Indications:Primary renal

Preclinical study
IND application
Clinical Phase I
Clinical Phase II
Clinical Phase III
HC0301
AKT-1
Primary hepatic
HC0301

Targets :AKT-1

Indications:Primary hepatic

Preclinical study
IND application
Clinical Phase I
Clinical Phase II
Clinical Phase III
HC009
Booster
COVID-19
HC009

Targets :Booster

Indications:COVID-19

Preclinical study
IND application
Clinical Phase I
Clinical Phase II
Clinical Phase III
HC016
TLR9
Cancer
HC016

Targets :TLR9

Indications:Cancer

Preclinical study
IND application
Clinical Phase I
Clinical Phase II
Clinical Phase III
High-end complex injection pipeline
Project code
Trade name of reference listed drug
Indications
Lab-scale development
Process technology transfer & Process validation
BE registration & BE study
ANDA application
HC007
Abraxane®
Lung cancer; breast cancer; pancreatic cancer etc.
HC007

Name:Abraxane®

Indications:Lung cancer; breast cancer; pancreatic cancer etc.

HC006
Onivyde®
Pancreatic cancer
HC006

Name:Onivyde®

Indications:Pancreatic cancer

HC008
Exparel®
Postoperative anesthesia; nerve-blocking analgesia
HC008

Name:Exparel®

Indications:Postoperative anesthesia; nerve-blocking analgesia

HC004
Ambisome®
Fungal infection
HC004

Name:Ambisome®

Indications:Fungal infection

+86-571-26262022